Kopran concludes EU GMP inspection of its Khopoli unit

Kopran announced that Medicine Authority European Union (EU)- conducted GMP inspection at the company's formulation, manufacturing facility located at Khopoli, from 18 September 2026 to 23 September 2026. The inspection was successfully concluded with No critical observations, one major observation and some minor observations and there were no data integrity related observations.

The Company is in the process to submit the compliance responses to the EU authorities within a fortnight.